Download FREE Report Sample
Download Free samplePlatinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
Platinum Anti-tumor Drugs Market contains market size and forecasts of Platinum Anti-tumor Drugs in Global, including the following market information:
Global Platinum Anti-tumor Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Platinum Anti-tumor Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cisplatin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Platinum Anti-tumor Drugs include Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical, Teva, Pfizer, Dr Reddy's Laboratories and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the Platinum Anti-tumor Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Platinum Anti-tumor Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Platinum Anti-tumor Drugs Market Segment Percentages, by Type, 2021 (%)
Cisplatin
Oxaliplatin
Carboplatin
Other
Global Platinum Anti-tumor Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Platinum Anti-tumor Drugs Market Segment Percentages, by Application, 2021 (%)
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Other
Global Platinum Anti-tumor Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Platinum Anti-tumor Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Platinum Anti-tumor Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Platinum Anti-tumor Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
